| pubmed-article:18760271 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0023895 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0015695 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0018595 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0015879 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:18760271 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:18760271 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:18760271 | pubmed:dateCreated | 2008-10-28 | lld:pubmed |
| pubmed-article:18760271 | pubmed:abstractText | The genetic polymorphism of haptoglobin (HP) has been associated with cardiovascular disease and type 2 diabetes. We hypothesized that the HP polymorphism could affect the incidence of nonalcoholic fatty liver disease (NAFLD). | lld:pubmed |
| pubmed-article:18760271 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18760271 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18760271 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18760271 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18760271 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18760271 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18760271 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18760271 | pubmed:issn | 0009-8981 | lld:pubmed |
| pubmed-article:18760271 | pubmed:author | pubmed-author:NakagawaKazuk... | lld:pubmed |
| pubmed-article:18760271 | pubmed:author | pubmed-author:MarubayashiTo... | lld:pubmed |
| pubmed-article:18760271 | pubmed:author | pubmed-author:HoriMasaharuM | lld:pubmed |
| pubmed-article:18760271 | pubmed:author | pubmed-author:NakagawaTakeh... | lld:pubmed |
| pubmed-article:18760271 | pubmed:author | pubmed-author:MiharaShuichi... | lld:pubmed |
| pubmed-article:18760271 | pubmed:author | pubmed-author:MuramotoYosuk... | lld:pubmed |
| pubmed-article:18760271 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18760271 | pubmed:volume | 398 | lld:pubmed |
| pubmed-article:18760271 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18760271 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18760271 | pubmed:pagination | 34-8 | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:meshHeading | pubmed-meshheading:18760271... | lld:pubmed |
| pubmed-article:18760271 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18760271 | pubmed:articleTitle | A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease. | lld:pubmed |
| pubmed-article:18760271 | pubmed:affiliation | Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. | lld:pubmed |
| pubmed-article:18760271 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18760271 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:3240 | entrezgene:pubmed | pubmed-article:18760271 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18760271 | lld:entrezgene |
